Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Survival Improvement in Human Retinal Pigment Epithelial Cells Via Fas Receptor Targeting by Mir-374A Publisher Pubmed



Tasharrofi N1, 2, 3 ; Kouhkan F3 ; Soleimani M4 ; Soheili ZS5 ; Kabiri M6 ; Mahmoudi Saber M1, 2, 7 ; Dorkoosh FA2, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Pharmacy, Department of Pharmaceutical Nanotechnology, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Faculty of Pharmacy, Department of Pharmaceutics, Tehran University of Medical Science, Tehran, Iran
  3. 3. Stem Cell Technology Research Center, Tehran, Iran
  4. 4. Faculty of Medical Science, Department of Hematology, Tarbiat Modares University, Tehran, Iran
  5. 5. Faculty of Molecular Medicine, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
  6. 6. Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran
  7. 7. Faculty of Pharmacy, Nanotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Faculty of Pharmacy, Medical Biomaterial Research Center (MBRC), Tehran University of Medical Science, No. 1462, Kargar Ave, Tehran, Iran

Source: Journal of Cellular Biochemistry Published:2017


Abstract

Oxidative conditions of the eye could contribute to retinal cells loss through activating the Fas-L/Fas pathway. This phenomenon is one of the leading causes of some ocular diseases like age-related macular degeneration (AMD). By targeting proteins at their mRNA level, microRNAs (miRNAs) can regulate gene expression and cell function. The aim of the present study is to investigate Fas targeting by miR-374a and find whether it can inhibit Fas-mediated apoptosis in primary human retinal pigment epithelial (RPE) cells under oxidative stress. So, the primary human RPE cells were transfected with pre-miR-374a pLEX construct using polymeric carrier and were exposed to H2O2 (200 μM) as an oxidant agent for induction of Fas expression. Fas expression at mRNA and protein level was evaluated by quantitative real-time PCR and Western blot analysis, respectively. These results revealed that miR-374a could prevent Fas upregulation under oxidative conditions. Moreover, Luciferase activity assay confirmed that Fas could be a direct target of miR-374a. The cell viability studies demonstrated that caspase-3 activity was negligible in miR-374a treated cells compared to the controls. Our data suggest miR-374a is a negative regulator of Fas death receptor which is able to enhance the cell survival and protect RPE cells against oxidative conditions. J. Cell. Biochem. 118: 4854–4861, 2017. © 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.